Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
First Claim
Patent Images
1. A pharmaceutical composition comprising from about 5% to about 95% weight/weight of a hydroxyethylquercetin-7-O-glucuronide, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent.
1 Assignment
0 Petitions
Accused Products
Abstract
Disclosed herein are metabolites of hydroxyethylrutoside (hydroxyethylquercetin-7-O-glucuronide), including compounds of Structural Formulas I, II, III and IV. The compounds disclosed are useful for inhibiting norepinephrine metabolism and in treating antenatal and postnatal depression in subjects in need thereof.
-
Citations
30 Claims
- 1. A pharmaceutical composition comprising from about 5% to about 95% weight/weight of a hydroxyethylquercetin-7-O-glucuronide, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent.
-
14. A pharmaceutical composition comprising:
from about 5% to about 95% weight/weight of a compound represented by the following structural formula; - View Dependent Claims (15, 16, 17, 18, 19, 20, 21, 22)
-
23. A pharmaceutical composition comprising:
a compound represented by the following structural formula; - View Dependent Claims (24, 25, 26, 27, 28, 29, 30)
Specification